ATI RN
ATI Pharmacology Final Exam 1 Questions
Extract:
Question 1 of 5
A client is receiving gabapentin, an anticonvulsant, but has no history of seizures. The nurse expects that the client is receiving this drug for which condition?
Correct Answer: B
Rationale: Gabapentin is used for neuropathic pain management.
Question 2 of 5
When giving chemotherapy as cancer treatment, the nurse recognizes that toxicity to rapidly growing normal cells also occurs. Which rapidly growing normal cells are also harmed by chemotherapy? (Select all that apply.)
Correct Answer: A,C,D
Rationale: Chemotherapy targets rapidly dividing cells, including GI mucosa, hair follicles, and bone marrow.
Question 3 of 5
A client with oliguria has an order for 1000 mL of 0.9% NS over 3 hours. The tubing drop factor is 10 gtt/mL. How many gtt/min should be given? (Round to the nearest whole number. use a leading zero if it applies. Do not use a trailing zero.)
Correct Answer: A
Rationale: Flow rate (gtt/min) = Volume (mL)/Time (min) × Drop factor (gtts/mL) = 1000/180 × 10 = 56 gtt/min.
Question 4 of 5
A client wants to take the herb gingko to help his memory. The nurse reviews his current medication list and would be concerned about potential interactions if he is taking a medication from which class of drugs?
Correct Answer: A
Rationale: Gingko has antiplatelet effects, increasing bleeding risk when combined with anticoagulants.
Question 5 of 5
The nurse is developing a care plan for a client who will be self-administering a metered-dose inhaler. Which statement reflects a measurable outcome?
Correct Answer: D
Rationale: Demonstration is a measurable outcome. It allows the nurse to pick any errors in the performance of the task in real time and hence corrections can be made.